PRESS RELEASE published on 05/31/2023 at 08:30, 1 year 5 months ago Business development in the first quarter of 2023 in line with expectations
PRESS RELEASE published on 04/28/2023 at 08:30, 1 year 6 months ago Revenues and earnings in line with expectations despite difficult market conditions
PRESS RELEASE published on 03/10/2023 at 11:15, 1 year 8 months ago Investors support refinancing transaction and pave way for further success course
PRESS RELEASE published on 03/03/2023 at 21:59, 1 year 8 months ago EQS-Adhoc: Refinancing of the 2020/2023 and the 2021/2026 bonds successfully completed
PRESS RELEASE published on 02/28/2023 at 18:04, 1 year 8 months ago EQS-Adhoc: Update on the Refinancing Process of 2020/2023 Bond and 2021/2026 Bond
PRESS RELEASE published on 02/10/2023 at 17:58, 1 year 9 months ago ACCENTRO is progressing well and provides update on status of refinancing process
PRESS RELEASE published on 01/11/2023 at 08:30, 1 year 10 months ago Bondholders Meeting overwhelmingly supports ACCENTRO's long-term refinancing concept
PRESS RELEASE published on 01/10/2023 at 12:46, 1 year 10 months ago EQS-Adhoc: Approval by the bondholders of ACCENTRO Real Estate AG’s 2020/2023 bond to the refinancing of the 2020/2023 bond
Published on 11/21/2024 at 13:30, 15 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 15 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 45 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 45 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 45 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 10 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 30 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
